Email: info@apollotherapeutics.comTranslating innovative science into therapeutic potential
Apollo Home 2018-04-17T12:12:23+00:00

Introducing Apollo Therapeutics

Apollo Therapeutics is a collaborative venture between three world-leading UK universities (Imperial College London, University College London and the University of Cambridge) and three global pharmaceutical companies (AstraZeneca, GlaxoSmithKline, Johnson & Johnson Innovation). It provides committed translational funding and drug discovery expertise for novel therapeutics, sourced from the best of British academic research, accelerating them towards the clinic.

Apollo’s unique model provides quick, independent access to the resources to grow innovations and to champion the best of British academic research to industry. Apollo’s experienced team of industry scientists have a proven track record of therapeutic delivery and work in partnership with academics and industry partners, crafting each bespoke project to optimise the chances of long-term success. Apollo Therapeutics aims to create the therapies of the future by partnering with the UK’s globally leading academic science base and UK based Pharma industry to have a real impact on patient treatments and outcomes.

Apollo Projects

VIEW ALL PROJECTS
Apollo Oncology
Apollo Respiratory
Apollo Neurology Opthalmology
Apollo Rare Diseases
Apollo Cardiovascular Metabolic
Apollo Infectious Disease

Apollo People

Apollo Drug Discovery Team

The drug discovery team are highly experienced applied scientists with expertise in the discovery and development of new experimental drugs from a range of modalities and therapeutic indications. The drug discovery team will work with academic scientists from each of the Universities to identify the best translational targets and to prosecute and deliver a pipeline of products for licensing

 
More
Apollo Investment Committee

The investment committee has sole responsibility for reviewing and endorsing the project proposals, plans, costs, timelines and licensing strategy proposed by the drug discovery team

 
More
Apollo LLP Committee

The LLP Committee have responsibility for the management and control of Apollo, including approval of the business plan, the annual budget and the setting of various key governance policies

 
More
Scientific Advisory Board

The Scientific Advisory board will meet annually and advise Apollo on science, portfolio and relevant emerging trends and priorities in the Biopharm and University environments

 
More

Apollo News

Apollo Therapeutics News & Press Releases

Apollo Therapeutics shortlisted for Biotech and Money’s ‘Life Science Spin-out of the Year’

August 2nd, 2017
By

Stevenage, 12 June 2017: Apollo Therapeutics (‘Apollo’), the collaborative venture between three world-leading UK universities and three global pharmaceutical companies, is pleases to announce that it has been shortlisted as a finalist in the ‘UK Life Science Spin-Out of the Year’ category of the Biotech and Money 2017 Awards.

ALL NEWS

Our Partners